SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

CollPlant Biotechnologies Ltd
Date: July 1, 2025 · CIK: 0001631487 · Accession: 0001213900-25-060354

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-288109

Date
July 1, 2025
Author
COLLPLANT BIOTECHNOLOGIES
Form
CORRESP
Company
CollPlant Biotechnologies Ltd

Letter

Re: CollPlant Biotechnologies Ltd.

CollPlant Biotechnologies Ltd.

4 Oppenheimer, Weizmann Science Park

Rehovot 7670104, Israel

July 1, 2025

Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549

Registration Statement on Form F-1 File No. 333-288109

VIA EDGAR

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, CollPlant Biotechnologies Ltd. (the " Registrant ") hereby respectfully requests that the effectiveness of the Registration Statement on Form F-1 (File No. 333-288109) of the Registrant (the " Registration Statement ") be accelerated so that the Company's Registration Statement will be declared effective at 4:30 p.m., Eastern Time, on July 3, 2025 or as soon thereafter as may be practicable.

The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, LLP, by calling Gary Emmanuel at (212) 801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.

Very truly yours,
COLLPLANT BIOTECHNOLOGIES
LTD.

Show Raw Text
CORRESP
 1
 filename1.htm

 CollPlant Biotechnologies Ltd.

 4 Oppenheimer, Weizmann
Science Park

 Rehovot 7670104, Israel

 July 1, 2025

 Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

 Re:
 CollPlant Biotechnologies Ltd.

 Registration Statement on Form F-1
 File No. 333-288109

 VIA EDGAR

 Ladies and Gentlemen:

 Pursuant to Rule 461 under the
Securities Act of 1933, as amended, CollPlant Biotechnologies Ltd. (the " Registrant ") hereby respectfully requests
that the effectiveness of the Registration Statement on Form F-1 (File No. 333-288109) of the Registrant (the " Registration Statement ")
be accelerated so that the Company's Registration Statement will be declared effective at 4:30 p.m., Eastern Time, on July 3, 2025
or as soon thereafter as may be practicable.

 The undersigned respectfully requests
that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, LLP, by calling
Gary Emmanuel at (212) 801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.

 Very truly yours,

 COLLPLANT BIOTECHNOLOGIES
LTD.

 By:
 /s/ Eran Rotem

 Name:
 Title:
 Eran Rotem Deputy CEO and Chief Financial Officer

 cc: Gary Emmanuel (Greenberg Traurig, LLP)